Why the study?
Does diltiazem prevent reperfusion-induced ventricular fibrillation in isolated rat hearts?
Does diltiazem prevent reperfusion-induced ventricular fibrillation in isolated rat hearts?
Diltiazem protects against reperfusion-induced arrhythmias in isolated rat hearts, likely mediated by its specific effect on the slow calcium channel.
Answers are grounded in this paper and cite their sources.
Diltiazem attenuates reperfusion VF in rat hearts; leaves open translation to human reperfusion injury and clinical trials.
This investigation was undertaken to define the mechanism by which diltiazem protects against life-thereatening, reperfusion-induced arrhythmias. Using an isolated retrogressively perfused rat heart preparation with transient coronary artery occlusion, we compared the effects of diltiazem in its active form (d-cis) to its stereo-isomer (1-cis). Pre-ischemic administration of d-diltiazem (5 × 10-8, 5 × 10-7, 5 × 10-6 M) caused a dose-dependent reduction in ventricular arrhythmias upon reperfusion following 10 min of regional ischemia. The incidence of reperfusion-induced ventricular fibrillation (RVF) was 50%, 0% (P<0.05) and 0% (P<0.05) with 5 × 10-8, 5 × 10-7, 5 × 10-6 M diltiazem, respectively, compared with 60% in the control group. Pre-ischemic administration of the 1-isomer caused different dose-dependent reduction in RVF. With 5 × 10-6M, the l-isomer also reduced the incidence of RVF to 0% (P<0.05). However below this concentration it was ineffective (67%). D-diltiazem (5 × 10-7 and 5 × 10-6M) increased coronary flow from 11.5 ± 1.9 ml/min to 15.3 ± 1.6 ml/min (p<0.05) and 15.2 ± 1.0 ml/min (p<0.05) respectively, prior to ischemia. In contrast. the same dose of the 1-isomer did not alter coronary flow. The highest dose (5 × 10-6M) of d-diltiazem decreased heart rate by approximately 30% during the reperfusion phase, but all other concentrations had no significant effects. The high-energy phosphate content of the ischemic myocardium was significantly elevated after treatment with diltiazem. ATP content was increased from 11.1 ± 3.7 μmol/g dry weight to 18.0 ± 1.8 μmol/g dry weight (p<0.05), 17.2 ± 2.9 μmol/g dry weight (p<0.05) and 17.9 ± 3.4 μmol/g dry weight (p<0.05) with 5 × 10-8, 5 × 10-7 and 5 × 10-6M diltiazem. The 1-isomer, at 5 × 10-7M, preserved ischemic myocardial creatine phosphate content (16.9 ± 5.6 μmol/g dry weight: p<0.05 compared to 6.2 ± 1.8 μmol/g dry, wt in the control group) however the ATP content was not significantly higher. Thus, effects of the drugs on coronary flow, heart rate and high-energy phosphate content failed to explain the anti-arrhythmic properties of diltiazem. We conclude that the protective effect of diltiazem against reperfusion-induced arrhythmias is mediated mainly by its specific effect on the slow calcium channel, although a sodium channel blocking effect may also play an additional role.
No takes yet. Share an insight, caveat, or question.
Mitani et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: